Studies in HCC cell lines confirmed that Ad5sPD1PVR can significantly enhance the antitumor efficacy mediated by CD8 + T cells, and it has a long-term tumor-specific immune monitoring effect [119]. Here, CD8A is linked to hepatocellular carcinoma.